Actor/arman-bd

ORCID Scraper: Researcher Profiles & Affiliations

Scrape public ORCID records: name, biography, employment and education history, funding, peer reviews and the full works list with DOIs. Search by name or fetch by iD.

Publisher description, verbatim
Last 7 dayson this actor
Each one reaches followers by email the morning after.Follow this actor
Key figures18 readings
Price / 1k$2.00per 1,000 researcher-scraped
Users / 30d1→ 0 over 18 readings
Users, all time2→ 0 over 18 readings
Runs / 30d16↑ 15 over 17 readings
Runs / user / mo16.0runs per monthly user
Standing
#4of 15

on ORCID, by users in the last 30 days among actors classified to this platform.

Recorded changes

No price, README, schema or grade changes in the last 30 days · followers get the next one by email.

History

18 readings since 2026-10-07
Users / 30d18 readings
10-07→ 010-24
Users, all time18 readings
10-07→ 010-24
Runs / 30d17 readings
10-07↑ 1510-24
Standing18 readings
10-07↑ 110-24

Alternatives on ORCID

The actors either side of #4 of 15, ranked by users in the last 30 days. Same platform, adjacent adoption — the comparable set.

all 15 on ORCID →
Sort
#ActorGradePrice / 1kUsers /30dSuccessRatingAgeFresh
1CRES$2.99 /1kfair price16688 total82.7%—22maging
2—RES$2.00 /1kgood price22 total——3mfresh
3—EVT$2.00 /1k researcher-fetched217 total——8maging
4—EVT$2.00 /1k researcher-scraped12 total——3mfreshThis
5—RES$1.50 /1kgood price12 total——3maging
6—EVT$3.00 /1k result-emitted12 total——51dfresh
7—RES$3.00 /1khigh price12 total——26dfresh
8—EVT$1.80 /1k researcher-profile11 total——4maging
9—RES$4.99 /1ksteep price12 total——9dfresh

Follow this actor, compare it against its rivals, and get every overnight change in one morning report.

Publish it yourself? Claim your publisher page and its full history is yours free, forever.

Open in the app Claim this page

Numbers on this page are measured only by an independent census of the Apify Store — not self-reported. Not indexed: too little has happened to this actor for us to have anything worth saying yet.